
Overview
John Varga is a Rheumatologist practicing medicine in Ann Arbor, Michigan.
Dr. Varga is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Localized Scleroderma.
Dr. Varga is board certified in Rheumatology and Internal Medicine. He is actively involved in clinical research, co-authoring 209 peer reviewed articles and participating in 5 clinical trials. Dr. Varga is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Center Dr, Floor 3 Reception A, Ann Arbor, MI 48109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Taubman Center
Dr. J. Michelle Kahlenberg MD, PhD is a physician scientist and Associate Professor of Internal Medicine at the University of Michigan. She completed her MD, PhD, and Internal Medicine training at Case Western Reserve University and completed her fellowship in Rheumatology at the University of Michigan. She joined the University of Michigan faculty in 2011, was appointed Assistant Professor in 2012, and was promoted to Associate Professor with tenure in 2018. She has been running her own laboratory and has been an active member of the Immunology Training Program since 2013. Her clinical work is centered on the care of complicated lupus patients, including those with refractory skin disease. Her R01-funded research laboratory combines translational approaches using patient samples and murine models to uncover the mechanisms that drive lupus and lupus flares. In particular, she is focused on unraveling the pathogenic mechanisms in cutaneous lupus, the factors that drive photosensitivity, and how skin inflammation can influence systemic lupus activity. Her work has received institutional accolades and national recognition from the Arthritis National Research Foundation, The Rheumatology Research Foundation, American Society for Clinical Investigation and the Lupus Foundation of America. In her spare time, she enjoys organic gardening, working on the family farm EMMA Acres run by her husband, Mark, and spending time with her husband and children. Dr. Kahlenberg is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus (SLE), Dermatomyositis, and Mevalonate Kinase Deficiency. Dr. Kahlenberg is board certified in Rheumatology. Dr. Kahlenberg is currently accepting new patients.
Taubman Center
Dr. Fox is a graduate of the Massachusetts Institute of Technology and Harvard Medical School. Following internal medicine residency and rheumatology fellowship at the Brigham and Women's Hospital, he joined the faculty of the University of Michigan School of Medicine in 1985. Dr. Fox is Professor of Internal Medicine and, from 1990 to 2018, was Chief of the Division of Rheumatology. In addition, he co-directs the University of Michigan Clinical Autoimmunity Center of Excellence. In 2013, Dr. Fox became the Frederick G. L. Huetwell and William D. Robinson, M.D. Professor of Rheumatology. Dr. Foxs research focuses on defining and characterizing pathways of human T cell activation, determining the role of these pathways in the pathogenesis of autoimmune disease, investigating T cell interactions with synovial fibroblasts, understanding the role of interleukin-17 in arthritis, and exploring novel approaches to the treatment of rheumatoid arthritis and scleroderma. He is author of more than 230 scientific papers and book chapters and has served on the Editorial Board of Arthritis & Rheumatism, as an Associate Editor and Section Editor of the Journal of Immunology and as an Associate Editor of the Journal of Clinical Investigation. His published work has been cited more than 10,000 times. He is a member of the American Society for Clinical Investigation and the Association of American Physicians. Dr. Fox is also active in the clinical care of patients with rheumatic diseases and in teaching students and fellows in both clinical and research settings. Dr. Fox has been an ACR ()American College of Rheumatology) member since 1985, an ACR volunteer since 1991, and an ACR Master since 2018. He has been a member of 12 ACR and RRF committees and task forces and chaired the Publications Committee, Finance Committee, and Monitoring Committee. In 2011-2012, Dr. Fox later co-chaired the ACR Task Force on Academic Rheumatology. From 2007-2008, Dr. Fox served as the seventy-first President of the American College of Rheumatology and the sixth ACR President from the University of Michigan. Dr. Fox currently holds leadership positions in the Immune Tolerance Network and in the Biomarkers Consortium of the Foundation for the NIH. Dr. Fox is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Scleroderma, Systemic Sclerosis (SSc), Adult Still's Disease, and Tissue Biopsy. Dr. Fox is currently accepting new patients.
Taubman Center
Dr. Knight received his M.D. and Ph.D. degrees from the University of Michigan and completed his molecular biology Ph.D. research in the laboratory of Dr. Erle Robertson at the University of Pennsylvania. His fellowship in rheumatology was at the University of Michigan, where he pursued postdoctoral research in the laboratory of Dr. Mariana Kaplan. During fellowship, he received the prestigious American College of Rheumatology Distinguished Fellow Award, as well as a Rheumatology Research Foundation Scientist Development Award.As a faculty member, he has been awarded the Jerome W. Conn Award for Excellence in Research by the Department of Internal Medicine. He has also received the Edmund L. Dubois Award for young lupus researchers from the American College of Rheumatology and the Mary Betty Stevens Young Investigator Prize from the Lupus Foundation of America. He is a member of the American Society for Clinical Investigation.His NIH-funded research laboratory has also received financial support from the Burroughs Wellcome Fund, Department of Defense, Lupus Research Alliance, and Rheumatology Research Foundation, His research group is working to better understand the triggers and effectors of autoimmunity in lupus and the related antiphospholipid syndrome (APS). His group is also interested in other diseases characterized by excessive neutrophil-mediated inflammation including diabetes and COVID-19.Dr. Knight is an international leader in the clinical care of APS patients and the role of inflammation in APS. Contact Dr. Knight if you are interested in participating in APS research studies. Dr. Knight is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Antiphospholipid Syndrome, Systemic Lupus Erythematosus (SLE), Takayasu Arteritis, and Granulomatosis with Polyangiitis. Dr. Knight is board certified in Rheumatology. Dr. Knight is currently accepting new patients.
Frequently Asked Questions about Dr. John A. Varga
How do I make an appointment with Dr. John A. Varga?
You can book an appointment with Dr. John A. Varga by calling their office at 888-229-3065. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. John A. Varga a top-rated expert for Scleroderma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. John A. Varga is classified as an Elite expert for Scleroderma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. John A. Varga specialize in?
While Dr. John A. Varga is a Rheumatology, they have specific expertise in Scleroderma, Systemic Sclerosis (SSc), and Scleroma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.
Does Dr. John A. Varga participate in research or clinical trials?
Yes. Dr. John A. Varga has published 209 articles and abstracts on conditions like Scleroderma. You can view a list of Dr. John A. Varga's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. John A. Varga accept my insurance?
Dr. John A. Varga accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 888-229-3065 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- SclerodermaDr. Varga isElite. Learn about Scleroderma.
- Systemic Sclerosis (SSc)Dr. Varga isElite. Learn about Systemic Sclerosis (SSc).
- Distinguished
- Localized SclerodermaDr. Varga isDistinguished. Learn about Localized Scleroderma.
- ScleromaDr. Varga isDistinguished. Learn about Scleroma.
- Advanced
- Pulmonary FibrosisDr. Varga isAdvanced. Learn about Pulmonary Fibrosis.
- Raynaud PhenomenonDr. Varga isAdvanced. Learn about Raynaud Phenomenon.
- Experienced
- ArthritisDr. Varga isExperienced. Learn about Arthritis.
- Eosinophilia-Myalgia SyndromeDr. Varga isExperienced. Learn about Eosinophilia-Myalgia Syndrome.
- Eosinophilic FasciitisDr. Varga isExperienced. Learn about Eosinophilic Fasciitis.
- Mixed Connective Tissue DiseaseDr. Varga isExperienced. Learn about Mixed Connective Tissue Disease.
- MyositisDr. Varga isExperienced. Learn about Myositis.
- Rheumatoid Arthritis (RA)Dr. Varga isExperienced. Learn about Rheumatoid Arthritis (RA).
- SarcoidosisDr. Varga isExperienced. Learn about Sarcoidosis.
- ScleredemaDr. Varga isExperienced. Learn about Scleredema.
- Sjogren SyndromeDr. Varga isExperienced. Learn about Sjogren Syndrome.
- Systemic Lupus Erythematosus (SLE)Dr. Varga isExperienced. Learn about Systemic Lupus Erythematosus (SLE).
- VEXAS SyndromeDr. Varga isExperienced. Learn about VEXAS Syndrome.


